CBUSCibus Inc. Class A Common Stock

1.700USD0.00%Mkt Cap: 129.93M $P/E:

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides…

HeadlineSourceTime
Older
Cibus Inc: Interoc Expands Rice Trade to 5 Traits, 36% Revenue Growth – Quarterly Update Report

Download the Complete Report Here Cibus, Inc. (CBUS) Interoc Expands Rice Pipeline to Five Traits; Platform Revenue and Cost Discipline Advance as LATAM Launch Moves to 2028 Key Takeaways: Rice commercialization advanced as Interoc testing began and the relationship expanded from two to five traits, although initial LATAM launch timing moved to 2028. Sustainable Ingredients […] The post Cibus Inc: Interoc Expands Rice Trade to 5 Traits, 36% Revenue Growth – Quarterly Update Report appeared first

EExec Edge
Cibus Inc: Interoc Expands Rice Trade to 5 Traits, 36% Revenue Growth – Downloadable Quarterly Update Report

Cibus, Inc. (CBUS) Interoc Expands Rice Pipeline to Five Traits; Platform Revenue and Cost Discipline Advance as LATAM Launch Moves to 2028 Read Exec Edge’s Initiation on Cibus, Inc. Here Subscribe to our Weekly Newsletter to Receive All Research Contact: Executives-Edge.com [email protected] The post Cibus Inc: Interoc Expands Rice Trade to 5 Traits, 36% Revenue Growth – Downloadable Quarterly Update Report appeared first on ExecEdge.

EExec Edge
Cibus, Inc. Q2 2026 Earnings Call Summary

Moby summary of Cibus, Inc.'s Q2 2026 earnings call

Moby
Cibus Inc (CBUS) (Q2 2026) Earnings Call Highlights: Strategic Pivot to Trait Pipeline Model ...

Despite a delayed rice launch and cash runway concerns, Cibus expands partnerships and advances regulatory approvals across key markets.

GuruFocus.com
Cibus Q2 Earnings Call Highlights

Cibus (NASDAQ:CBUS) reported second-quarter 2026 revenue of $1.0 million, compared with $0.9 million a year earlier, as the agricultural biotechnology company advanced its Sustainable Ingredients program and updated the expected timing of its initial rice launch in Latin America. For the first six

MarketBeat
Cibus (CBUS) Reports Q2 Loss, Misses Revenue Estimates

Cibus (CBUS) delivered earnings and revenue surprises of -11.54% and -29.50%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
Alico (ALCO) Surpasses Q3 Earnings and Revenue Estimates

Alico (ALCO) delivered earnings and revenue surprises of +139.73% and +247.69%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks
Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection

Download the Complete Report Here Cibus, Inc. (CBUS) Rice Royalty Conversion, Precision-Breeding Platform, and BioFragrance Scale-Up Support Commercial Inflection CBUS is an asset-light precision-breeding platform that develops productivity traits for seed-company partners, rather than owning seed production, distribution or farmer relationships. RTDS and the Trait Machine process are designed to edit elite customer germplasm and […] The post Cibus Inc’s Precision-Breeding Platform and BioFragra

EExec Edge
Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection – Downloadable Initiation Report

Cibus, Inc. (CBUS) Rice Royalty Conversion, Precision-Breeding Platform, and BioFragrance Scale-Up Support Commercial Inflection Subscribe to our Weekly Newsletter to Receive All Research Contact: Executives-Edge.com [email protected] The post Cibus Inc’s Precision-Breeding Platform and BioFragrance Scale-Up Support Commercial Inflection – Downloadable Initiation Report appeared first on ExecEdge.

EExec Edge
Cibus (CBUS) Welcomes Landmark EU Crop Breeding Decision

Cibus, Inc. (NASDAQ:CBUS) is one of the 10 Fastest Growing Tech Penny Stocks to Buy. On June 17, 2026, Cibus, Inc. (NASDAQ:CBUS) welcomed a landmark European Union decision under which crops improved without adding foreign DNA will be treated like conventionally bred crops rather than transgenic GMOs. Cibus said the decision opens a path for […]

IInsider Monkey